Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 47 min ago
PreprintAll rights reservedmedRxiv

Analytical validation and amyloid-status discrimination of a high-throughput, research-use-only plasma p-Tau217 immunoassay

  • P. Wynveen
  • A. Becker
  • S. Levin
  • B. Dumke
  • N. Hoekstra
  • K. Hoffmann
  • C. Knutson
  • J. Lengfeld
  • P. Li
  • J. Radcliff
  • K. Bhatt
  • H. Zetterberg
4 more authors
  • A. L. Benedet
  • M. Holland
  • C. M. Carlson
  • J. S. Hinson1
  1. 1Danaher Diagnostics, Washington, DC USA
Read full textPDFDOICite

Related

  1. Identifying and resolving analytical outliers in lipoprotein(a) immunoassay testing
    Alexandria N. Jackson, Sara P. Wyness, Joseph W. Rudolf +1
    Practical laboratory medicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Biomarker Convert: a novel approach to transform plasma pTau217 results across immunoassay and mass spectrometry analytical platforms
    K. J. Quadrini, J. Aubrecht, F. Vernhes +9
    medRxivPreprintAll rights reservedFull textNeurologymedRxiv
  3. Validation of plasma biomarker immunoassay‐based models for predicting brain amyloid positivity in cognitively impaired individuals
    Jeremy A. Syrjanen, Daniel J. Figdore, Michael E. Griswold +13
    Alzheimer's & DementiaPeer-reviewedCC BY-NC 4.0Full textPsychiatry & mental healthPMC
  4. Identification and validation of feature genes using a ferroptosis-informed analytical framework in medulloblastoma
    Xin Chen, Sen Li, Kunfang Yang +2
    Frontiers in pediatricsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Analytical and clinical validation of the EdenDx methylation assay as a noninvasive supportive triage tool for early detection of endometrial cancer in cervical scraping specimens
    Gynecologic oncology reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{wynveen2026analytical,
  title = {{Analytical validation and amyloid-status discrimination of a high-throughput, research-use-only plasma p-Tau217 immunoassay}},
  author = {P. Wynveen and A. Becker and S. Levin and B. Dumke and N. Hoekstra and K. Hoffmann and C. Knutson and J. Lengfeld and P. Li and J. Radcliff and K. Bhatt and H. Zetterberg and A. L. Benedet and M. Holland and C. M. Carlson and J. S. Hinson},
  howpublished = {medRxiv},
  year = {2026},
  month = aug,
  doi = {10.64898/2026.08.31.26361836},
  url = {https://www.medrxiv.org/content/10.64898/2026.08.31.26361836v1},
}
RIS
TY  - UNPB
TI  - Analytical validation and amyloid-status discrimination of a high-throughput, research-use-only plasma p-Tau217 immunoassay
AU  - P. Wynveen
AU  - A. Becker
AU  - S. Levin
AU  - B. Dumke
AU  - N. Hoekstra
AU  - K. Hoffmann
AU  - C. Knutson
AU  - J. Lengfeld
AU  - P. Li
AU  - J. Radcliff
AU  - K. Bhatt
AU  - H. Zetterberg
AU  - A. L. Benedet
AU  - M. Holland
AU  - C. M. Carlson
AU  - J. S. Hinson
PY  - 2026
DA  - 2026/08/31
PB  - medRxiv
DO  - 10.64898/2026.08.31.26361836
UR  - https://www.medrxiv.org/content/10.64898/2026.08.31.26361836v1
ER  -